{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:22:39Z","timestamp":1648650159184},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00347-020-01237-9","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T14:08:43Z","timestamp":1602166123000},"page":"106-112","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Experimentelle Therapieans\u00e4tze f\u00fcr die Behandlung retinaler Dystrophien bei neuronalen Ceroid-Lipofuszinosen"],"prefix":"10.1007","volume":"118","author":[{"given":"Susanne","family":"Bartsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Bassal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Jankowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"1237_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","volume":"1832","author":"GW Anderson","year":"2013","unstructured":"Anderson\u00a0GW, Goebel\u00a0HH, Simonati\u00a0A (2013) Human pathology in NCL. Biochim Biophys Acta 1832:1807\u20131826","journal-title":"Biochim Biophys Acta"},{"key":"1237_CR2","doi-asserted-by":"publisher","first-page":"14185","DOI":"10.1038\/s41598-019-50726-8","volume":"9","author":"Y Atiskova","year":"2019","unstructured":"Atiskova\u00a0Y, Bartsch\u00a0S, Danyukova\u00a0T et al (2019) Mice deficient in the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1) display a\u00a0complex retinal phenotype. Sci Rep 9:14185","journal-title":"Sci Rep"},{"key":"1237_CR3","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1167\/iovs.13-12945","volume":"54","author":"U Bartsch","year":"2013","unstructured":"Bartsch\u00a0U, Galliciotti\u00a0G, Jofre\u00a0GF et\u00a0al (2013) Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis. Invest Ophthalmol Vis Sci 54:6952\u20136959","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1237_CR4","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.bbadis.2013.01.009","volume":"1832","author":"M Bond","year":"2013","unstructured":"Bond\u00a0M, Holthaus\u00a0SM, Tammen\u00a0I et\u00a0al (2013) Use of model organisms for the study of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 1832:1842\u20131865","journal-title":"Biochim Biophys Acta"},{"key":"1237_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I","volume":"77","author":"RT Bronson","year":"1998","unstructured":"Bronson\u00a0RT, Donahue\u00a0LR, Johnson\u00a0KR et\u00a0al (1998) Neuronal ceroid lipofuscinosis (nclf), a\u00a0new disorder of the mouse linked to chromosome 9. Am J Med Genet 77:289\u2013297","journal-title":"Am J Med Genet"},{"key":"1237_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","volume":"126","author":"EY Chew","year":"2019","unstructured":"Chew\u00a0EY, Clemons\u00a0TE, Jaffe\u00a0GJ et\u00a0al (2019) Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial. Ophthalmology 126:540\u2013549","journal-title":"Ophthalmology"},{"key":"1237_CR7","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.bbadis.2015.04.022","volume":"1852","author":"KM Faller","year":"2015","unstructured":"Faller\u00a0KM, Gutierrez-Quintana\u00a0R, Mohammed\u00a0A et al (2015) The neuronal ceroid lipofuscinoses: opportunities from model systems. Biochim Biophys Acta 1852:2267\u20132278","journal-title":"Biochim Biophys Acta"},{"key":"1237_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","volume":"12","author":"M Griffey","year":"2005","unstructured":"Griffey\u00a0M, Macauley\u00a0SL, Ogilvie\u00a0JM et al (2005) AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis. Mol Ther 12:413\u2013421","journal-title":"Mol Ther"},{"key":"1237_CR9","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1073\/pnas.251485198","volume":"98","author":"P Gupta","year":"2001","unstructured":"Gupta\u00a0P, Soyombo\u00a0AA, Atashband\u00a0A et\u00a0al (2001) Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S\u00a0A 98:13566\u201313571","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1237_CR10","doi-asserted-by":"publisher","first-page":"e0127204","DOI":"10.1371\/journal.pone.0127204","volume":"10","author":"W Jankowiak","year":"2015","unstructured":"Jankowiak\u00a0W, Kruszewski\u00a0K, Flachsbarth\u00a0K et al (2015) Sustained neural stem cell-based Intraocular delivery of CNTF attenuates photoreceptor loss in the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS ONE 10:e127204","journal-title":"PLoS ONE"},{"key":"1237_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","volume":"15","author":"TB Johnson","year":"2019","unstructured":"Johnson\u00a0TB, Cain\u00a0JT, White\u00a0KA et\u00a0al (2019) Therapeutic landscape for Batten disease: current treatments and future prospects. Nat Rev Neurol 15:161\u2013178","journal-title":"Nat Rev Neurol"},{"key":"1237_CR12","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/jnr.23423","volume":"92","author":"ML Katz","year":"2014","unstructured":"Katz\u00a0ML, Coates\u00a0JR, Sibigtroth\u00a0CM et al (2014) Enzyme replacement therapy attenuates disease progression in a\u00a0canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease). J\u00a0Neurosci Res 92:1591\u20131598","journal-title":"J Neurosci Res"},{"key":"1237_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ymthe.2018.02.027","volume":"26","author":"SM Kleine Holthaus","year":"2018","unstructured":"Kleine Holthaus\u00a0SM, Ribeiro\u00a0J, Abelleira-Hervas\u00a0L et al (2018) Prevention of photoreceptor cell loss in a\u00a0Cln6(nclf) mouse model of batten disease requires CLN6 gene transfer to bipolar cells. Mol Ther 26:1343\u20131353","journal-title":"Mol Ther"},{"key":"1237_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","volume":"33","author":"A Kohlschutter","year":"2019","unstructured":"Kohlschutter\u00a0A, Schulz\u00a0A, Bartsch\u00a0U et\u00a0al (2019) Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs 33:315\u2013325","journal-title":"CNS Drugs"},{"key":"1237_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1637200","author":"ARA Marques","year":"2019","unstructured":"Marques\u00a0ARA, Di Spiezio\u00a0A, Thiessen\u00a0N et al (2019) Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2019.1637200","journal-title":"Autophagy"},{"key":"1237_CR16","doi-asserted-by":"publisher","first-page":"e75963","DOI":"10.1371\/journal.pone.0075963","volume":"8","author":"M Mirza","year":"2013","unstructured":"Mirza\u00a0M, Volz\u00a0C, Karlstetter\u00a0M et\u00a0al (2013) Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a\u00a0beneficial effect of DHA and curcumin supplementation. Plos One 8:e75963","journal-title":"Plos One"},{"key":"1237_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","volume":"18","author":"SE Mole","year":"2019","unstructured":"Mole\u00a0SE, Anderson\u00a0G, Band\u00a0HA et\u00a0al (2019) Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 18:107\u2013116","journal-title":"Lancet Neurol"},{"key":"1237_CR18","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1002\/j.1460-2075.1995.tb00029.x","volume":"14","author":"P Saftig","year":"1995","unstructured":"Saftig\u00a0P, Hetman\u00a0M, Schmahl\u00a0W et\u00a0al (1995) Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO\u00a0J 14:3599\u20133608","journal-title":"EMBO J"},{"key":"1237_CR19","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz\u00a0A, Ajayi\u00a0T, Specchio\u00a0N et\u00a0al (2018) Study of Intraventricular cerliponase alfa for CLN2 disease. N\u00a0Engl J Med 378:1898\u20131907","journal-title":"N Engl J Med"},{"key":"1237_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2353\/ajpath.2010.091267","volume":"177","author":"Z Shevtsova","year":"2010","unstructured":"Shevtsova\u00a0Z, Garrido\u00a0M, Weishaupt\u00a0J et al (2010) CNS-expressed cathepsin D prevents lymphopenia in a\u00a0murine model of congenital neuronal ceroid lipofuscinosis. Am J Pathol 177:271\u2013279","journal-title":"Am J Pathol"},{"key":"1237_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.exer.2016.09.003","volume":"152","author":"CJ Tracy","year":"2016","unstructured":"Tracy\u00a0CJ, Whiting\u00a0RE, Pearce\u00a0JW et al (2016) Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis. Exp Eye Res 152:77\u201387","journal-title":"Exp Eye Res"},{"key":"1237_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","volume":"125","author":"RE Whiting","year":"2014","unstructured":"Whiting\u00a0RE, Narfstrom\u00a0K, Yao\u00a0G et\u00a0al (2014) Enzyme replacement therapy delays pupillary light reflex deficits in a\u00a0canine model of late infantile neuronal ceroid lipofuscinosis. Exp Eye Res 125:164\u2013172","journal-title":"Exp Eye Res"},{"key":"1237_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108130","author":"REH Whiting","year":"2020","unstructured":"Whiting\u00a0REH, Pearce\u00a0JW, Vansteenkiste\u00a0DP et\u00a0al (2020) Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis. Exp Eye Res. https:\/\/doi.org\/10.1016\/j.exer.2020.108130","journal-title":"Exp Eye Res"},{"key":"1237_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108135","author":"REH Whiting","year":"2020","unstructured":"Whiting\u00a0REH, Robinson\u00a0GO, Ota-Kuroki\u00a0J et al (2020) Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis. Exp Eye Res. https:\/\/doi.org\/10.1016\/j.exer.2020.108135","journal-title":"Exp Eye Res"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-020-01237-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T14:11:02Z","timestamp":1633702262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-020-01237-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1237"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01237-9","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"8 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Bartsch, J.\u00a0Liu, M.\u00a0Bassal, W.\u00a0Jankowiak, M.S.\u00a0Spitzer und U.\u00a0Bartsch geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}